Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension

Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension

Objectives: Evidence has shown that angiotensin-converting enzyme 2 (ACE2), which can be upregulated after angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) treatment, may play a dual role in the pathogenesis and progression of coronavirus disease 2019 (COVID-19)....

Full description

Bibliographic Details
Main Authors: Jing Ma, Xiaowei Shi, Jiong Yu, Feifei Lv, Jian Wu, Xinyu Sheng, Qiaoling Pan, Jinfeng Yang, Hongcui Cao, Lanjuan Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
angiotensin-converting enzyme inhibitors
angiotensin receptor blockers
COVID-19
hypertension
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.577398/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.577398/full

Similar Items